Global Lung Cancer Liquid Biopsy Market Companies

Healthcare
Nov 2022
Global
350 Pages
No of Tables: 220
No of Figures: 60

Buy Now

Request for Sample

Nucleus

Companies Covered

Highest Market Share

Dominant Companies

Other Companies

Global Lung Cancer Liquid Biopsy Market Share Analysis

The data presented is for visualization purposes only and may not reflect actual results.

Nucleus : Company Analysis Platform

Request for Demo >

Frequently Asked Questions

What are the primary segments covered in the Global Lung Cancer Liquid Biopsy Market report?

The market is segmented based on , By Biomarker Type (CTC (Circulating Tumor Cells), ctDNA (Circulating tumor DNA), Exosomes and RNA), Application (Small Cell Lung Cancer and Non-Small Cell Lung Cancer), End-User (Diagnostic and Imaging Centres, Hospitals, Academic and Research Centers and Others) – Industry Trends and Forecast to 2030. .

What is the current market size of the Global Lung Cancer Liquid Biopsy Market?

The Global Lung Cancer Liquid Biopsy Market size was valued at USD 0.30 USD Billion in 2022.

What is the expected growth rate of the Global Lung Cancer Liquid Biopsy Market?

The Global Lung Cancer Liquid Biopsy Market is projected to grow at a CAGR of 21% during the forecast period of 2023 to 2030.

Who are the key players in the Global Lung Cancer Liquid Biopsy Market?

The major players operating in the market include Eurofins Scientific , MDxHealth , CareDx , Immucor , Thermo Fisher Scientific Inc. , Menarini Silicon Biosystems , QIAGEN , Guardant Health , Exact Sciences Corporation , Myriad GeneticsInc. , LungLife AIInc. , Bio-Rad LaboratoriesInc. AGilent Technologies Inc. , NateraInc. , CARDIFF ONCOLOGYInc. , Exosome Diagnostics Inc. , IlluminaInc. , Genomic Health Inc. and F. Hoffmann-La Roche Ltd .

Which countries are analyzed in the Global Lung Cancer Liquid Biopsy Market report?

The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.